Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 1 (2024)

Stepwise implementation of an enhanced recovery pathway for elective total hip arthroplasty in a Swiss hospital: a cohort study

  • Simon Heinrich
  • Simon Gratza
  • Anke Eckardt
  • Thomas Ilchmann
DOI
https://doi.org/10.57187/s.3537
Cite this as:
Swiss Med Wkly. 2024;154:3537
Published
22.01.2024

Summary

BACKGROUND: Enhanced recovery programs after total hip arthroplasty have been shown to reduce hospital length of stay without compromising results, but yet there is a lack of data for the Swiss population. Therefore, this retrospective cohort study evaluated whether similar positive effects on clinical outcomes are present in the context of the Swiss healthcare system.

METHODS: Patients who underwent elective primary total hip arthroplasty were analysed. The baseline group comprised 50 patients treated consecutively by one surgeon in 2013 according to the clinical practice guidelines. Another surgeon implemented a new standardised treatment protocol in April 2014. In January 2018, this protocol was followed by an enhanced recovery program that integrated all care providers at the hospital. The data of the baseline group (series 0) and four series of 50 patients each, two treated with the standardised treatment protocol (series 1–2) and two treated with the enhanced recovery program (series 3–4), were analysed. All patients had follow-ups at 6 weeks and 3 months after surgery. The primary outcomes were length of stay and discharge destination; the secondary outcomes were admission on the day of surgery (instead of one day prior), the use of urinary catheters, the administration of opioids, the difference between pre- and postoperative haemoglobin, blood transfusions, and adverse events within 3 months of surgery.

RESULTS: The median length of stay was 10 days in the baseline group and only 5 days after the implementation of the standardised protocol and enhanced recovery program in series 4 (p <0.001). The percentage of patients discharged directly home was higher in series 4 than in the baseline group (84% vs. 66%, p = 0.085). Patients admitted to the hospital on the day of surgery increased from 2% in series 0 to 98% in series 4 (p <0.001). The use of urinary catheters was significantly higher in the baseline group (100% of patients) than in series 3 and 4 (0%) (p <0.001), and the number of patients who did not require opioids was significantly higher in series 4 than in series 0 (36% vs. 10%, p = 0.007). The median blood loss (500 ml vs. 300 ml, p <0.001), median difference in pre- and postoperative haemoglobin (29 g/dl vs. 25 g/dl, p = 0.145), and number of blood transfusions (5 vs. 2 p = 0.99) were higher in the baseline group than in series 4. The number of adverse events did not differ significantly between groups (p = 0.699).

CONCLUSIONS: Almost all parameters examined in this study showed improvement, whereas the rate of adverse events was not affected and remained low. The presented data can be used as a benchmark, but details of these findings need to be confirmed in larger cohorts.

References

  1. Health at a Glance 2017 | READ online. OECD iLibrary https://read.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-en
  2. Antrobus JD, Bryson GL. Enhanced recovery for arthroplasty: good for the patient or good for the hospital? Can J Anaesth. 2011 Oct;58(10):891–4. 10.1007/s12630-011-9564-9
  3. Raphael M, Jaeger M, van Vlymen J. Easily adoptable total joint arthroplasty program allows discharge home in two days. Can J Anaesth. 2011 Oct;58(10):902–10. 10.1007/s12630-011-9565-8
  4. Fawcett WJ, Mythen MG, Scott MJ. Enhanced recovery: more than just reducing length of stay? Br J Anaesth. 2012 Nov;109(5):671–4. 10.1093/bja/aes358
  5. Okamoto T, Ridley RJ, Edmondston SJ, Visser M, Headford J, Yates PJ. Day-of-Surgery Mobilization Reduces the Length of Stay After Elective Hip Arthroplasty. J Arthroplasty. 2016 Oct;31(10):2227–30. 10.1016/j.arth.2016.03.066
  6. Husted H. Fast-track hip and knee arthroplasty: clinical and organizational aspects. Acta Orthop Suppl. 2012 Oct;83(346):1–39. 10.3109/17453674.2012.700593
  7. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity.
  8. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.1
  9. Zhu S, Qian W, Jiang C, Ye C, Chen X. Enhanced recovery after surgery for hip and knee arthroplasty: a systematic review and meta-analysis. Postgrad Med J. 2017 Dec;93(1106):736–42. 10.1136/postgradmedj-2017-134991
  10. Schneider M, Kawahara I, Ballantyne G, McAuley C, Macgregor K, Garvie R, et al. Predictive factors influencing fast track rehabilitation following primary total hip and knee arthroplasty. Arch Orthop Trauma Surg. 2009 Dec;129(12):1585–91. 10.1007/s00402-009-0825-9
  11. Napier RJ, Spence D, Diamond O, O’Brien S, Walsh T, Beverland DE. Modifiable factors delaying early discharge following primary joint arthroplasty. Eur J Orthop Surg Traumatol. 2013 Aug;23(6):665–9. 10.1007/s00590-012-1053-5
  12. OECD. Health at a Glance 2019: OECD Indicators. OECD; 2019. 10.1787/4dd50c09-en
  13. Husted H, Gromov K, Malchau H, Freiberg A, Gebuhr P, Troelsen A. Traditions and myths in hip and knee arthroplasty. Acta Orthop. 2014 Dec;85(6):548–55. 10.3109/17453674.2014.971661
  14. Swiss National Hip and Knee Joint Registry. Report 2020. Internet: https://www.anq.ch/wp-content/uploads/2021/01/ANQakut_SIRIS_Hips-Knee_Annual-Report_2020.pdf
  15. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br. 2009 Jun;91(6):776–83. 10.1302/0301-620X.91B6.22393
  16. Alecci V, Valente M, Crucil M, Minerva M, Pellegrino CM, Sabbadini DD. Comparison of primary total hip replacements performed with a direct anterior approach versus the standard lateral approach: perioperative findings. J Orthop Traumatol. 2011 Sep;12(3):123–9. 10.1007/s10195-011-0144-0
  17. Yoshihara H, Yoneoka D. National trends in the utilization of blood transfusions in total hip and knee arthroplasty. J Arthroplasty. 2014 Oct;29(10):1932–7. 10.1016/j.arth.2014.04.029
  18. Bedard NA, Pugely AJ, Lux NR, Liu SS, Gao Y, Callaghan JJ. Recent Trends in Blood Utilization After Primary Hip and Knee Arthroplasty. J Arthroplasty. 2017 Mar;32(3):724–7. 10.1016/j.arth.2016.09.026
  19. Saleh E, McClelland DB, Hay A, Semple D, Walsh TS. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth. 2007 Dec;99(6):801–8. 10.1093/bja/aem299
  20. Loftus TJ, Spratling L, Stone BA, Xiao L, Jacofsky DJ. A Patient Blood Management Program in Prosthetic Joint Arthroplasty Decreases Blood Use and Improves Outcomes. J Arthroplasty. 2016 Jan;31(1):11–4. 10.1016/j.arth.2015.07.040
  21. Madsen RV, Nielsen CS, Kallemose T, Husted H, Troelsen A. Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty. J Arthroplasty. 2017 Apr;32(4):1298–303. 10.1016/j.arth.2016.10.015
  22. Husted H, Solgaard S, Hansen TB, Søballe K, Kehlet H. Care principles at four fast-track arthroplasty departments in Denmark. Dan Med Bull. 2010 Jul;57(7):A4166.
  23. Schlosser MJ, Korwek KM, Dunn R, Poland RE. Reduced post-operative opioid use decreases length of stay and readmission rates in patients undergoing hip and knee joint arthroplasty. J Orthop. 2020 Mar;21:88–93. 10.1016/j.jor.2020.03.003
  24. Huang Z, Ma J, Shen B, Pei F. General anesthesia: to catheterize or not? A prospective randomized controlled study of patients undergoing total knee arthroplasty. J Arthroplasty. 2015 Mar;30(3):502–6. 10.1016/j.arth.2014.09.028
  25. Bjerregaard LS, Homilius M, Bagi P, Hansen TB, Kehlet H. Indwelling urinary catheterisation may increase risk of complications in hip and knee arthroplasty. Dan Med J. 2019 Apr;66(4).
  26. Bjerregaard LS, Bogø S, Raaschou S, Troldborg C, Hornum U, Poulsen AM, et al. Incidence of and risk factors for postoperative urinary retention in fast-track hip and knee arthroplasty. Acta Orthop. 2015 Apr;86(2):183–8. 10.3109/17453674.2014.972262
  27. Bjerregaard LS, Jorgensen CC, Kehlet H; Lundbeck Foundation Centre for Fast-Track Hip and Knee Replacement Collaborative Group. Serious renal and urological complications in fast-track primary total hip and knee arthroplasty; a detailed observational cohort study. Minerva Anestesiol. 2016 Mar.
  28. Berg U, BüLow E, Sundberg M, Rolfson O. No increase in readmissions or adverse events after implementation of fast-track program in total hip and knee replacement at 8 Swedish hospitals: an observational before-and-after study of 14,148 total joint replacements 2011-2015. Acta Orthop. 2018 Oct;89(5):522–7. 10.1080/17453674.2018.1492507
  29. de Pablo P, Losina E, Phillips CB, Fossel AH, Mahomed N, Lingard EA, et al. Determinants of discharge destination following elective total hip replacement. Arthritis Rheum. 2004 Dec;51(6):1009–17. 10.1002/art.20818
  30. MacDonald V, Ottem P, Wasdell M, Spiwak R. Predictors of prolonged hospital stays following hip and knee arthroplasty. Int J Orthop Trauma Nurs. 2010;14(4):198–205. 10.1016/j.ijotn.2010.06.001
  31. Jørgensen CC, Kehlet H; Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Role of patient characteristics for fast-track hip and knee arthroplasty. Br J Anaesth. 2013 Jun;110(6):972–80. 10.1093/bja/aes505
  32. Husted H. Fast-track hip and knee arthroplasty: clinical and organizational aspects. Acta Orthop Suppl. 2012 Oct;83(346):1–39. 10.3109/17453674.2012.700593
  33. Füssenich W, Gerhardt DM, Pauly T, Lorenz F, Olieslagers M, Braun C, et al. A comparative health care inventory for primary hip arthroplasty between Germany versus the Netherlands. Is there a downside effect to fast-track surgery with regard to patient satisfaction and functional outcome? Hip Int. 2020 Jul;30(4):423–30. 10.1177/1120700019876881
  34. Büttner M, Mayer AM, Büchler B, Betz U, Drees P, Susanne S. Economic analyses of fast-track total hip and knee arthroplasty: a systematic review. Eur J Orthop Surg Traumatol. 2020 Jan;30(1):67–74. 10.1007/s00590-019-02540-1
  35. Nöth U, Rackwitz L, Clarius M. [Challenges of fast-track arthroplasty in Germany]. Orthopade. 2020 Apr;49(4):334–7.
  36. Nöth U, Geiser T, Kranich T, von Rottkay E, Reichert JC, Reyle-Hahn M, et al. [Fast track strategies in hip arthroplasty]. Orthopade. 2019 Apr;48(4):330–6.
  37. Petersen PB, Jørgensen CC, Kehlet H; Lundbeck Foundation Center for Fast-track Hip and Knee Replacement collaborative group. Temporal trends in length of stay and readmissions after fast-track hip and knee arthroplasty. Dan Med J. 2019 Jul;66(7).
  38. Galakatos GR. Direct Anterior Total Hip Arthroplasty. Mo Med. 2018;115(6):537–41.
  39. Ilchmann T. Approaches for primary total hip replacement. Hip Int. 2014 Oct;24(10_suppl Suppl 10):S2–6. 10.5301/hipint.5000163
  40. Lloyd JM, Wainwright T, Middleton RG. What is the role of minimally invasive surgery in a fast track hip and knee replacement pathway? Ann R Coll Surg Engl. 2012 Apr;94(3):148–51. 10.1308/003588412X13171221590214
  41. Dall GF, Ohly NE, Ballantyne JA, Brenkel IJ. The influence of pre-operative factors on the length of in-patient stay following primary total hip replacement for osteoarthritis: a multivariate analysis of 2302 patients. J Bone Joint Surg Br. 2009 Apr;91(4):434–40. 10.1302/0301-620X.91B4.21505
  42. Husted H, Jensen CM, Solgaard S, Kehlet H. Reduced length of stay following hip and knee arthroplasty in Denmark 2000-2009: from research to implementation. Arch Orthop Trauma Surg. 2012 Jan;132(1):101–4. 10.1007/s00402-011-1396-0